Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$10.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ellex Medical Lasers Ltd announces acquisition of north american glaucoma treatment consumable device business and completion of A$3 mln capital raise


Thursday, 19 Dec 2013 05:52pm EST 

Ellex Medical Lasers Ltd:Says has entered into agreement to acquire North American glaucoma consumable device business.Says for commercial reasons, the name if the company cannot be identified until after settlement of transaction expected to occur on Dec. 31.Says gross proceeds of A$3 mln under the placement will fund the upfront $1.6 mln consideration of the acquisition while remaining funds will be applied to working capital.Says the placement of 10 mln shares was completed at an issue price of A$0.30 per share raising A$3 mln and represents a 6.25 pct discount to the closing price of the company's shares on the ASX on Dec 17.Says it expects that placement share will be issued on Dec. 30. 

Company Quote

0.27
 --
19 Dec 2014